ATE363481T1 - Pyrazolderivate als gnrh-inhibitoren - Google Patents
Pyrazolderivate als gnrh-inhibitorenInfo
- Publication number
- ATE363481T1 ATE363481T1 AT03792484T AT03792484T ATE363481T1 AT E363481 T1 ATE363481 T1 AT E363481T1 AT 03792484 T AT03792484 T AT 03792484T AT 03792484 T AT03792484 T AT 03792484T AT E363481 T1 ATE363481 T1 AT E363481T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- compounds
- pyrazole derivatives
- gnrh inhibitors
- gnrh
- Prior art date
Links
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 title 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 title 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 229940121381 gonadotrophin releasing hormone (gnrh) antagonists Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Detergent Compositions (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02292075 | 2002-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE363481T1 true ATE363481T1 (de) | 2007-06-15 |
Family
ID=31896980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03792484T ATE363481T1 (de) | 2002-08-21 | 2003-08-19 | Pyrazolderivate als gnrh-inhibitoren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7253290B2 (de) |
| EP (1) | EP1539743B1 (de) |
| JP (1) | JP2006501231A (de) |
| AT (1) | ATE363481T1 (de) |
| AU (1) | AU2003255811A1 (de) |
| DE (1) | DE60314158T2 (de) |
| ES (1) | ES2286493T3 (de) |
| WO (1) | WO2004018459A1 (de) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997021707A1 (en) | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| PL327146A1 (en) | 1995-12-14 | 1998-11-23 | Merck & Co Inc | Antagonists of the gonadotrophin liberating hormone |
| KR19990072124A (ko) | 1995-12-14 | 1999-09-27 | 애쉬톤 왈레이스 티 | 고나도트로핀 방출 호르몬의 길항제 |
| US6200957B1 (en) * | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1997021435A1 (en) | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2254769A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU729663B2 (en) | 1997-06-05 | 2001-02-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP0986550A1 (de) | 1997-06-05 | 2000-03-22 | Merck & Co., Inc. | Antagonisten des gonadotropin freisetzenden hormons |
| US6156772A (en) | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP0986385A4 (de) | 1997-06-05 | 2001-05-16 | Merck & Co Inc | Antagonisten des gonadorelins |
| WO1998055123A1 (en) | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1998055119A1 (en) | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP1027046A4 (de) | 1997-10-28 | 2002-04-03 | Merck & Co Inc | Antagonisten des gonadotropin freisetzenden hormons |
| AU1197299A (en) | 1997-10-28 | 1999-05-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2318957A1 (en) | 1998-02-11 | 1999-08-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2317451A1 (en) | 1998-02-11 | 1999-08-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1999051595A1 (en) | 1998-04-02 | 1999-10-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP1070064A1 (de) | 1998-04-02 | 2001-01-24 | Merck & Co., Inc. | Antagonisten des gonadotropin freisetzenden hormons |
| AU3210799A (en) | 1998-04-02 | 1999-10-25 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1999051234A1 (en) | 1998-04-02 | 1999-10-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2325995A1 (en) | 1998-04-02 | 1999-10-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP1067930A4 (de) | 1998-04-02 | 2002-09-18 | Merck & Co Inc | Antagonisten des gonadoliberins |
| EP1161431A4 (de) | 1999-03-10 | 2002-04-24 | Merck & Co Inc | 6-azaindol-verbindungen als antagonisten des gonadotropin-freisetzungs hormones |
| AU3396000A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| AU3868900A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| WO2000053178A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| CA2367130A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| EP1165075A4 (de) | 1999-03-10 | 2002-04-10 | Merck & Co Inc | 6-azaindolverbindungen als antagonisten des gonadoliberins |
| SE0100566D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| SE0101692D0 (sv) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
-
2003
- 2003-08-19 AU AU2003255811A patent/AU2003255811A1/en not_active Abandoned
- 2003-08-19 DE DE60314158T patent/DE60314158T2/de not_active Expired - Fee Related
- 2003-08-19 US US10/525,111 patent/US7253290B2/en not_active Expired - Fee Related
- 2003-08-19 AT AT03792484T patent/ATE363481T1/de not_active IP Right Cessation
- 2003-08-19 EP EP03792484A patent/EP1539743B1/de not_active Expired - Lifetime
- 2003-08-19 ES ES03792484T patent/ES2286493T3/es not_active Expired - Lifetime
- 2003-08-19 JP JP2004530359A patent/JP2006501231A/ja active Pending
- 2003-08-19 WO PCT/GB2003/003623 patent/WO2004018459A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004018459A1 (en) | 2004-03-04 |
| JP2006501231A (ja) | 2006-01-12 |
| US7253290B2 (en) | 2007-08-07 |
| AU2003255811A1 (en) | 2004-03-11 |
| DE60314158T2 (de) | 2008-01-31 |
| EP1539743B1 (de) | 2007-05-30 |
| EP1539743A1 (de) | 2005-06-15 |
| US20050239858A1 (en) | 2005-10-27 |
| ES2286493T3 (es) | 2007-12-01 |
| DE60314158D1 (de) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0100568D0 (sv) | Compounds | |
| EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
| EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| ATE400573T1 (de) | 1h-imidazochinolinderivate als proteinkinaseinhibitoren | |
| IS2376B (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
| SG171471A1 (en) | New benzimidazole derivatives | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| SE0100569D0 (sv) | New compounds | |
| DE60217843D1 (de) | Ein dioxinoä2,3-güchinolin-9-carbonsäure derivat als nk3 rezeptor antagonist | |
| WO2004017961A3 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
| ATE342264T1 (de) | Indolderivate und deren verwendung als gnrh antagonisten | |
| SE0102055D0 (sv) | New Compounds | |
| ATE368040T1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren | |
| PT1165544E (pt) | 1,4-di-hidroindeno¬1,2-c|pirazoles substituidos como inibidores de tirosina-quinase | |
| ATE384066T1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
| DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| SE0101692D0 (sv) | Compounds | |
| DE60314158D1 (de) | Pyrazolderivate als gnrh-inhibitoren | |
| SE0403117D0 (sv) | New compounds 1 | |
| SE0401716D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |